Introduction to the Lower Respiratory System

Core Concepts

The airway tree: from trachea to bronchioles

Air leaving the larynx enters the trachea (windpipe), a tube reinforced by C-shaped cartilage rings that keep it open. The trachea divides into the right and left main bronchi — the right is wider, shorter, and more vertical, which is why aspirated objects and liquids more often enter the right lung. The bronchi branch again and again into smaller bronchioles, progressively losing cartilage and gaining smooth muscle, until they become the smallest conducting airways — the bronchial tree. Two features matter for pharmacology:

• Airway smooth muscle surrounds the bronchi and bronchioles. When it contracts (bronchoconstriction), the airway narrows and airflow resistance rises; when it relaxes (bronchodilation), the airway opens. The autonomic nervous system controls this: parasympathetic (cholinergic) stimulation narrows the airways, while sympathetic stimulation via beta-2 receptors dilates them. This is the exact mechanism behind two major drug classes in Chapter 25: beta-2 adrenergic agonists (bronchodilators that relax the muscle) and anticholinergics (which block the narrowing signal).
• Mucus production and clearance continue here. Goblet cells and submucosal glands make mucus, and cilia keep sweeping it upward (the mucociliary escalator begun in the upper airway). In COPD, mucus becomes thick and excessive and cilia are damaged — a major reason secretions accumulate.

The respiratory zone: where gas exchange happens

The conducting airways give way to the respiratory zone: respiratory bronchioles, alveolar ducts, and finally the alveoli — clusters of tiny, thin-walled air sacs. Several design features make the alveoli ideal for their job:

• Enormous surface area — the alveoli of both lungs together provide a surface roughly the size of a tennis court, maximizing the area available for gas exchange.
• Extremely thin walls — each alveolus is lined by a single layer of flattened cells (Type I pneumocytes), so oxygen and carbon dioxide cross a very short distance to reach the blood in surrounding capillaries.
• Surfactant — Type II pneumocytes secrete surfactant, a soap-like substance that coats the alveoli and lowers surface tension. Without it, the tiny air sacs would collapse on every breath out (as happens in premature infants with respiratory distress syndrome).

Each alveolus is wrapped in a dense capillary network, and the shared wall between air and blood — the alveolar-capillary membrane — is the actual site of gas exchange, covered in detail in the next topic.

The pleura and lung structure

Each lung is enclosed in a double-layered sac, the pleura: the visceral pleura clings to the lung surface, and the parietal pleura lines the chest wall. Between them is a potential space containing a thin film of fluid that lets the lungs slide against the chest wall as they expand and recoil. The right lung has three lobes and the left lung two (leaving room for the heart); the lungs contain no muscle — they inflate and deflate passively as the diaphragm and chest wall move the pleura and create pressure changes. Air (pneumothorax) or fluid (pleural effusion) in the pleural space can compress the lung and impair breathing — an obstructive problem distinct from airway narrowing.

The lungs' defense systems

The lower airway defends itself with the same toolkit as the upper airway — mucus, cilia, and immune cells — plus two specialized mechanisms. Alveolar macrophages patrol the air sacs, engulfing inhaled particles and bacteria; they are the lung's cleanup crew. Mast cells, found in the airway wall, hold histamine and other inflammatory mediators that are released when triggered — in allergic asthma, this release drives bronchoconstriction, mucus production, and inflammation. This is why mast cell stabilizers (Chapter 25) work: they reduce mediator release, and why anti-inflammatory drugs are central to asthma management — inflammation, not just spasm, narrows the airways.

How disease changes the lower airway

Putting the anatomy together explains the hallmark diseases:

• In asthma, airway smooth muscle spasms (reversible bronchoconstriction), mucus plugs form, and the airway wall becomes inflamed — so treatment combines bronchodilators for the spasm and anti-inflammatory drugs for the underlying inflammation.
• In COPD, long-term damage (most often from smoking) destroys alveolar walls (emphysema), narrows the small airways (chronic bronchitis), and reduces elastic recoil, so airways tend to collapse on expiration — treatment focuses on bronchodilation and symptom management, with the structural damage itself largely irreversible.
• In pneumonia, the air sacs fill with fluid and immune cells, so gas exchange across the thickened membrane is impaired — a ventilation problem with an infectious cause.

The nurse's assessment language follows directly: wheezing = narrowed conducting airways, crackles = fluid or secretions in the air spaces, prolonged expiration = increased airway resistance (as in COPD), and tachypnea with accessory muscle use = the body working harder to move air. Scope note: assessment, inhaler teaching, and monitoring are core nursing work; diagnosis, spirometry interpretation, and prescribing are provider responsibilities and vary by scope and setting.

Common Confusions